Fosfomycin 8 Gm Sachet - Physical Form: Powder

50 Box/Boxes

50 Piece/Pieces

100 Strip/Strips

As Per Suggestions

3gm

10 Days

7 Days

Product Name: FOSFOFAST 4 Injection Brand: FOSFOFAST 4 Content / Active Ingredient: Fosfomycin Sodium Injection Strength: 4 g per vial Company / Manufacturer: BDR Pharmaceutical Pack Size: 4 g Vial (Dry Powder for Injection) Product Description FOSFOFAST 4 Injection is a sterile injectable antibiotic formulation containing Fosfomycin Sodium 4 g, a broad-spectrum bactericidal agent used in the treatment of serious bacterial infections. It is supplied as a dry powder for reconstitution and is intended for intravenous administration under the supervision of a qualified healthcare professional. Fosfomycin Sodium works by inhibiting bacterial cell wall synthesis at an early stage, making it effective against a wide range of Gram-positive and Gram-negative organisms, including certain multidrug-resistant strains. It is commonly used in hospital settings for moderate to severe infections. Key Features Composition: Fosfomycin Sodium 4 g per vial Therapeutic Category: Antibiotic Phosphonic acid derivative Dosage Form: Sterile dry powder for IV injection/infusion Route of Administration: Intravenous (IV) use only Prescription Status: Schedule H Prescription medicine Packaging: 4 g single vial pack Storage: Store in a cool, dry place below recommended temperature Indications / Uses FOSFOFAST 4 Injection is indicated for the treatment of: Severe urinary tract infections Respiratory tract infections Intra-abdominal infections Septicemia (bloodstream infections) Bone and joint infections Infections caused by multidrug-resistant organisms Dosage and duration should be determined by a qualified healthcare professional based on infection severity and patient condition. How It Works Fosfomycin inhibits the initial step of bacterial cell wall synthesis by blocking the formation of peptidoglycan, leading to bacterial cell death. Important Notes To be administered only by trained healthcare professionals. Monitor renal function and electrolyte levels during prolonged therapy. Possible side effects include nausea, diarrhea, headache, rash, and injection-site reactions.

Azathioprine (25 mg).